Renal Proximal Tubular Cells: A New Site for Targeted Delivery Therapy of Diabetic Kidney Disease

Overview

Journal Pharmaceuticals (Basel)

Publisher MDPI

Specialty Chemistry

Date 2022 Dec 23

PMID 36558944

Authors

Hao Li

Wenni Dai

Zhiwen Liu

Liyu He

Affiliations

Soon will be listed here.

Abstract

Diabetic kidney disease (DKD) is a major complication of diabetes mellitus (DM) and the leading cause of end-stage kidney disease (ESKD) worldwide. A significant number of drugs have been clinically investigated for the treatment of DKD. However, a large proportion of patients still develop end-stage kidney disease unstoppably. As a result, new effective therapies are urgently needed to slow down the progression of DKD. Recently, there is increasing evidence that targeted drug delivery strategies such as large molecule carriers, small molecule prodrugs, and nanoparticles can improve drug efficacy and reduce adverse side effects. There is no doubt that targeted drug delivery strategies have epoch-making significance and great application prospects for the treatment of DKD. In addition, the proximal tubule plays a very critical role in the progression of DKD. Consequently, the purpose of this paper is to summarize the current understanding of proximal tubule cell-targeted therapy, screen for optimal targeting strategies, and find new therapeutic approaches for the treatment of DKD.

Citing Articles

Early Diagnosis and Treatment of Kidney Injury: A Focus on Urine Protein.

Zeng D, Wang B, Xiao Z, Wang X, Tang X, Yao X Int J Mol Sci. 2024; 25(20).

PMID: 39456955 PMC: 11508809. DOI: 10.3390/ijms252011171.

4-Octyl itaconate attenuates renal tubular injury in db/db mice by activating Nrf2 and promoting PGC-1α-mediated mitochondrial biogenesis.

Shao M, Chen J, Zhang F, Su Q, Lin X, Wang W Ren Fail. 2024; 46(2):2403653.

PMID: 39291665 PMC: 11411562. DOI: 10.1080/0886022X.2024.2403653.

A new perspective on proteinuria and drug therapy for diabetic kidney disease.

Zhang R, Wang Q, Li Y, Li Q, Zhou X, Chen X Front Pharmacol. 2024; 15:1349022.

PMID: 39144629 PMC: 11322372. DOI: 10.3389/fphar.2024.1349022.

Nanomedicines for the management of diabetic nephropathy: present progress and prospects.

Paul P, Chacko L, Dua T, Chakraborty P, Paul U, Phulchand V Front Endocrinol (Lausanne). 2023; 14:1236686.

PMID: 38027185 PMC: 10656621. DOI: 10.3389/fendo.2023.1236686.

Feature Reviews in Pharmaceutical Technology.

Zustiak S, Jain E Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895807 PMC: 10609981. DOI: 10.3390/ph16101336.

References

Paluszkiewicz P, Martuszewski A, Zareba N, Wala K, Banasik M, Kepinska M . The Application of Nanoparticles in Diagnosis and Treatment of Kidney Diseases. Int J Mol Sci. 2022; 23(1). PMC: 8745391. DOI: 10.3390/ijms23010131. View

Dolman M, Harmsen S, Pieters E, Sparidans R, Lacombe M, Szokol B . Targeting of a platinum-bound sunitinib analog to renal proximal tubular cells. Int J Nanomedicine. 2012; 7:417-33. PMC: 3273977. DOI: 10.2147/IJN.S26485. View

Haraguchi R, Kohara Y, Matsubayashi K, Kitazawa R, Kitazawa S . New Insights into the Pathogenesis of Diabetic Nephropathy: Proximal Renal Tubules Are Primary Target of Oxidative Stress in Diabetic Kidney. Acta Histochem Cytochem. 2020; 53(2):21-31. PMC: 7212204. DOI: 10.1267/ahc.20008. View

Mukherjee A, Waters A, Kalyan P, Singh Achrol A, Kesari S, Yenugonda V . Lipid-polymer hybrid nanoparticles as a next-generation drug delivery platform: state of the art, emerging technologies, and perspectives. Int J Nanomedicine. 2019; 14:1937-1952. PMC: 6430183. DOI: 10.2147/IJN.S198353. View

Hasanein Asfour M, Salama A, Mohsen A . Fabrication of All-Trans Retinoic Acid loaded Chitosan/Tripolyphosphate Lipid Hybrid Nanoparticles as a Novel Oral Delivery Approach for Management of Diabetic Nephropathy in Rats. J Pharm Sci. 2021; 110(9):3208-3220. DOI: 10.1016/j.xphs.2021.05.007. View

Chen Z, Zhang W, Chen X, Hsu C . Trends in end-stage kidney disease in Shanghai, China. Kidney Int. 2019; 95(1):232. DOI: 10.1016/j.kint.2018.08.044. View

Trump D, Mathias C, Yang Z, Low P, Marmion M, Green M . Synthesis and evaluation of 99mTc(CO)(3)-DTPA-folate as a folate-receptor-targeted radiopharmaceutical. Nucl Med Biol. 2002; 29(5):569-73. DOI: 10.1016/s0969-8051(02)00310-4. View

Wang Y, Xia H, Chen B, Wang Y . Rethinking nanoparticulate polymer-drug conjugates for cancer theranostics. Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2022; 15(1):e1828. DOI: 10.1002/wnan.1828. View

Hu J, Li S, Kang X, Qi J, Wu J, Wang X . CD44-targeted hyaluronic acid-curcumin prodrug protects renal tubular epithelial cell survival from oxidative stress damage. Carbohydr Polym. 2018; 193:268-280. DOI: 10.1016/j.carbpol.2018.04.011. View

10.

Liu Z, Liu H, Xiao L, Liu G, Sun L, He L . STC-1 ameliorates renal injury in diabetic nephropathy by inhibiting the expression of BNIP3 through the AMPK/SIRT3 pathway. Lab Invest. 2019; 99(5):684-697. DOI: 10.1038/s41374-018-0176-7. View

11.

Filipczak N, Pan J, Yalamarty S, Torchilin V . Recent advancements in liposome technology. Adv Drug Deliv Rev. 2020; 156:4-22. DOI: 10.1016/j.addr.2020.06.022. View

12.

Ahangarpour A, Oroojan A, Khorsandi L, Kouchak M, Badavi M . Antioxidant, anti-apoptotic, and protective effects of myricitrin and its solid lipid nanoparticle on streptozotocin-nicotinamide-induced diabetic nephropathy in type 2 diabetic male mice. Iran J Basic Med Sci. 2020; 22(12):1424-1431. PMC: 7043868. DOI: 10.22038/IJBMS.2019.13989. View

13.

Williams R, Shah J, Ng B, Minton D, Gudas L, Park C . Mesoscale nanoparticles selectively target the renal proximal tubule epithelium. Nano Lett. 2015; 15(4):2358-64. PMC: 4518714. DOI: 10.1021/nl504610d. View

14.

Zou Z, Chung B, Nguyen T, Mentone S, Thomson B, Biemesderfer D . Linking receptor-mediated endocytosis and cell signaling: evidence for regulated intramembrane proteolysis of megalin in proximal tubule. J Biol Chem. 2004; 279(33):34302-10. DOI: 10.1074/jbc.M405608200. View

15.

Chai H, Kiew L, Chin Y, Norazit A, Noor S, Lo Y . Renal targeting potential of a polymeric drug carrier, poly-l-glutamic acid, in normal and diabetic rats. Int J Nanomedicine. 2017; 12:577-591. PMC: 5245978. DOI: 10.2147/IJN.S111284. View

16.

Wang D, Li S, Tan X, Wang J, Hu Y, Tan Z . Engineering of stepwise-targeting chitosan oligosaccharide conjugate for the treatment of acute kidney injury. Carbohydr Polym. 2021; 256:117556. DOI: 10.1016/j.carbpol.2020.117556. View

17.

Stan R, Kubitza M, Palade G . PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci U S A. 1999; 96(23):13203-7. PMC: 23925. DOI: 10.1073/pnas.96.23.13203. View

18.

Lin Y, Li Y, Wang X, Gong T, Zhang L, Sun X . Targeted drug delivery to renal proximal tubule epithelial cells mediated by 2-glucosamine. J Control Release. 2013; 167(2):148-56. DOI: 10.1016/j.jconrel.2013.02.001. View

19.

Geng H, Lan R, Liu Y, Chen W, Wu M, Saikumar P . Proximal tubule LPA1 and LPA2 receptors use divergent signaling pathways to additively increase profibrotic cytokine secretion. Am J Physiol Renal Physiol. 2021; 320(3):F359-F374. PMC: 7988817. DOI: 10.1152/ajprenal.00494.2020. View

20.

Zhang J, Wang Y, Gurung P, Wang T, Li L, Zhang R . The relationship between the thickness of glomerular basement membrane and renal outcomes in patients with diabetic nephropathy. Acta Diabetol. 2018; 55(7):669-679. DOI: 10.1007/s00592-018-1128-9. View